Investment Analysts’ updated eps estimates for Tuesday, October 13th:
AbbVie (NYSE:ABBV) had its outperform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $280.00 target price on the stock.
ACADIA Pharmaceuticals (NASDAQ:ACAD) was downgraded by analysts at UBS Group AG from a buy rating to a neutral rating. They currently have $23.00 price target on the stock.
BCE (NYSE:BCE) (TSE:BCE) was upgraded by analysts at Canaccord Genuity Group Inc. from a hold rating to a buy rating.
Contineum Therapeutics (NASDAQ:CTNM) was downgraded by analysts at Robert W. Baird from an outperform rating to a neutral rating. They currently have $14.00 price target on the stock.
Domino’s Pizza (NASDAQ:DPZ) had its hold rating reiterated by analysts at TD Cowen. They currently have a $320.00 target price on the stock.
Enerflex (NYSE:EFXT) was upgraded by analysts at Canadian Imperial Bank of Commerce from a neutral rating to a sector outperform rating.
Gemini Space Station (NASDAQ:GEMI) was upgraded by analysts at Citigroup Inc. from a sell rating to a neutral rating. They currently have $4.75 target price on the stock.
GE Vernova (NYSE:GEV) had its buy rating reiterated by analysts at Guggenheim. Guggenheim currently has a $1,450.00 price target on the stock.
Greencore Group (LON:GNC) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 185 price target on the stock.
Genus (LON:GNS) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 3,350 target price on the stock.
Harmony Biosciences (NASDAQ:HRMY) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $55.00 target price on the stock.
International Business Machines (NYSE:IBM) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $270.00 price target on the stock.
Incyte (NASDAQ:INCY) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $152.00 target price on the stock.
IonQ (NYSE:IONQ) had its buy rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $100.00 price target on the stock.
Kodal Minerals (LON:KOD) had its speculative buy rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 0.70 target price on the stock.
Lantheus (NASDAQ:LNTH) had its neutral rating reissued by analysts at Mizuho. They currently have a $109.00 target price on the stock, down from their previous target price of $115.00.
Lancashire (LON:LRE) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a GBX 691 target price on the stock.
MongoDB (NASDAQ:MDB) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $430.00 target price on the stock.
Meta Platforms (NASDAQ:META) had its buy rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $886.00 price target on the stock.
Meta Platforms (NASDAQ:META) had its overweight rating reissued by analysts at KeyCorp. The firm currently has a $900.00 target price on the stock.
Micron Technology (NASDAQ:MU) had its buy rating reaffirmed by analysts at Rosenblatt Securities. The firm currently has a $1,900.00 price target on the stock.
Nurix Therapeutics (NASDAQ:NRIX) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $34.00 price target on the stock.
NatWest Group (NYSE:NWG) was upgraded by analysts at Barclays PLC from an equal weight rating to an overweight rating.
Ollie’s Bargain Outlet (NASDAQ:OLLI) was upgraded by analysts at Gordon Haskett from an accumulate rating to a buy rating. Gordon Haskett currently has $105.00 price target on the stock.
Palisade Bio (NASDAQ:PALI) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $7.00 target price on the stock.
Pershing Square (NYSE:PS) had its underperform rating reaffirmed by analysts at Bank of America Corporation. Bank of America Corporation currently has a $38.00 target price on the stock, down from their previous target price of $54.00.
Radware (NASDAQ:RDWR) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.
Rexford Industrial Realty (NYSE:REXR) was upgraded by analysts at Mizuho from a neutral rating to an outperform rating. The firm currently has $41.00 target price on the stock, up from their previous target price of $38.00.
Securitize (NYSE:SECZ) was downgraded by analysts at Citigroup Inc. from a buy rating to a neutral rating. The firm currently has $14.00 price target on the stock.
Syndax Pharmaceuticals (NASDAQ:SNDX) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $38.00 target price on the stock.
Spire Global (NYSE:SPIR) was upgraded by analysts at Alliance Global Partners from a neutral rating to a buy rating. They currently have $15.00 price target on the stock.
Tharisa (LON:THS) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 230 price target on the stock.
TIM (NYSE:TIMB) was upgraded by analysts at Bank of America Corporation from an underperform rating to a neutral rating.
Travis Perkins (LON:TPK) had its underperform rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 453 price target on the stock.
Unilever (LON:ULVR) had its underperform rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a GBX 4,000 price target on the stock.
Unity Bancorp (NASDAQ:UNTY) had its buy rating reiterated by analysts at DA Davidson. The firm currently has a $68.00 price target on the stock.
Telefonica Brasil (NYSE:VIV) was upgraded by analysts at Bank of America Corporation from an underperform rating to a neutral rating.
YouGov (LON:YOU) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 395 price target on the stock.
Zenas BioPharma (NASDAQ:ZBIO) had its buy rating reissued by analysts at HC Wainwright. They currently have a $44.00 target price on the stock.
Receive News & Ratings for AbbVie Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbbVie Inc and related companies with MarketBeat.com's FREE daily email newsletter.
